Healthcare Professionals

Patient Adherence

Equally important to ensuring our patients are able to access and afford their oral chemotherapy drugs is ensuring that patients are adherent to their drug regimen and taking them properly.

Poor adherence has been associated with suboptimal responses to cancer treatment. For example, in this study of CML treatment with imatinib, adherence of less than 90% was associated with inadequate response as measured by molecular studies, and adherence of less than 80% was associated with NO response.

The following teaching tools developed by Multinational Association of Supportive Care in Cancer (MASCC) can help healthcare professionals educate their patients about the importance of taking their medication as prescribed.

MASCC Oral Agent Teaching Tool (MOATT):

Chemotherapy Regimen & Drug Information

Please use the Cancer Ontario drug formulary link below for information on drug and regimen monographs and symptom management information as well as patient drug information such as:

Product monographs contain:

  • Mechanism of action and pharmacokinetics
  • Adverse events
  • Dosing
  • Administration guidelines
  • Special precautions
  • Recommended clinical monitoring
  • Funding

Patient drug information handouts contain:

  • What the drug is used for
  • Pregnancy and breastfeeding concerns
  • How the drug is given
  • Storage
  • What to do while on the drug
  • Side effects and what to do

Cancer Ontario Drug Formulary

Please use the following link for information on drug and regimen monographs, symptom management information, and patient drug information